MUSTOPHORAN 208mg powder + solvent infusion solution medication leaflet

L01AD05 fotemustine • Antineoplastic and immunomodulating agents | Alkylating agents | Nitrosoureas

Fotemustine is a cytostatic medication used in the treatment of certain types of cancer, especially advanced malignant melanoma and some brain tumors. It works by inhibiting the division of cancer cells, slowing down or stopping their growth in the body.

Fotemustine is administered intravenously under strict medical supervision, usually in a hospital or oncology center. The dose and treatment schedule are determined by the doctor based on the type and stage of cancer, as well as the patient's general condition.

Side effects may include a decrease in blood cell counts, nausea, vomiting, fatigue, infections, or impaired liver function. In some cases, allergic reactions or lung problems may occur. Careful monitoring is essential throughout the treatment.

Fotemustine is an effective medication for certain forms of cancer, but its use involves risks and requires continuous medical supervision. Follow your doctor's instructions closely and report any unusual symptoms to prevent complications.

General data about MUSTOPHORAN 208mg

Substance: fotemustine

Date of last drug list: 01-06-2025

Commercial code: W03251001

Concentration: 208mg

Pharmaceutical form: powder + solvent infusion solution

Quantity: 1

Product type: original

Price: 1103.15 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: CENEXI - LABORATOIRES THISSEN S.A. - BELGIA

Holder: LES LABORATOIRES SERVIER - FRANTA

Number: 12574/2019/01

Shelf life: 2 years; after reconstitution-sol. trebuie utilizata imediat

Other substances similar to fotemustine